Pablo Moreno Llorente

Pablo Moreno Llorente

Auto-generated profile, based on publicly available information

Pablo Moreno Llorente

Unit of Endocrine Surgery, Department of Surgery, Hospital Universitari de Bellvitge, Universitat de Barcelona (UB) , Barcelona

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Surgery
Verified
Journal Article
Closed access
PMPablo Moreno
Pablo Moreno
ABAitor De La Quintana Basarrate
Aitor De La Quintana Basarrate
TMThomas J Musholt
Thomas J Musholt
IPIvan Paunovic
Ivan Paunovic
MPMarco Puccini
Marco Puccini
JRJosé M Ramia
José M Ramia

9 August 2022 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
PMPablo Moreno‐Llorente
Pablo Moreno‐Llorente
AGArantxa García‐Barrasa
Arantxa García‐Barrasa
MPMireia Pascua‐Solé
Mireia Pascua‐Solé
SVSebastian Videla
Sebastian Videla
Aurema OteroAurema Otero
Aurema Otero
JNJosé Luis Muñoz de Nova
José Luis Muñoz de Nova

1 January 2020 in JAMA Surgery
Verified
Journal Article
Closed access
PDF file
PLPablo Moreno Llorente
Pablo Moreno Llorente
JMJosé Manuel Francos Martínez
José Manuel Francos Martínez
ABArantxa García Barrasa
Arantxa García Barrasa
This study compares the efficacy of intraoperative parathyroid hormone measurement vs indocyanine green angiography of parathyroid glands in predicting early po

24 September 2021 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
PLPablo Moreno Llorente
Pablo Moreno Llorente
ABArantxa García Barrasa
Arantxa García Barrasa
JMJosé Manuel Francos Martínez
José Manuel Francos Martínez
MPMarta Alberich Prats
Marta Alberich Prats
MSMireia Pascua Solé
Mireia Pascua Solé

8 May 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PMPablo Moreno-Llorente
Pablo Moreno-Llorente
GGGuillermo García-González
Guillermo García-González
MPMireia Pascua-Solé
Mireia Pascua-Solé
AGArantxa García-Barrasa
Arantxa García-Barrasa
SVSebastian Videla
Sebastian Videla
JNJosé Luis Muñoz de Nova
José Luis Muñoz de Nova
Introduction: Angiography with indocyanine green (ICG) fluorescence performed before thyroidectomy would allow identification of the vascularization of parathyroid glands, maximizing efforts for preserving functioning glands intraoperatively. The rationale of the study was based on the hypothesis that showing the vascular pattern of the parathyroid glands by means of ICG angiography before performing the thyroidectomy could prevent permanent hypoparathyroidism.Methods and analysis: We propose a randomized single-blind controlled and multicenter clinical trial to assess the efficacy and safety of ICG angiography-guided thyroidectomy to identify the vascular pattern of the parathyroid glands versus conventional thyroidectomy in patients scheduled for elective total thyroidectomy. Patients will be randomized 1:1 to ICG angiography-guided thyroidectomy (experimental group) or conventional thyroidectomy (control group). Patients in the experimental group will undergo ICG angiography before thyroidectomy to identify the feeding vessels of the parathyroid glands and then, post-thyroidectomy ICG angiography to predict immediate parathyroid gland function by scoring the degree of fluorescence of the glands. Patients in the control group will undergo post-thyroidectomy ICG angiography only. The primary outcome measure will be the rate of patients with permanent hypoparathyroidism. Secondary outcome measures will be rate of postoperative hypoparathyroidism, the percentage of well vascularized parathyroid glands remaining in situ, the levels of iPTH and serum calcium after surgery and the influence of the type of vascular pattern of the parathyroid glands over these outcomes, as well as the safety profile of ICG angiography.Discussion: The results will contribute to adopt a new surgical strategy based on intraoperative ICG angiography before performing total thyroidectomy, according to which the rate of permanent hypoparathyroidism could be substantially reduced.Clinical trial registration: ClinicalTrials.gov. identifier NCT05573828.

17 July 2023 in Frontiers in Surgery
Verified
Journal Article
Open access
PMPablo Moreno-Llorente
Pablo Moreno-Llorente
MPMireia Pascua-Solé
Mireia Pascua-Solé
AGArantxa García-Barrasa
Arantxa García-Barrasa
JMJosé Luis Muñoz-De-Nova
José Luis Muñoz-De-Nova
Background: Postoperative hypoparathyroidism is the most common complication after total thyroidectomy and, when becomes permanent, lead to a myriad of clinical symptoms, long-term need of calcium and vitamin D supplementation and negative impact on the patient's health-related quality of life. Any surgical innovation that could reduce complications and improve outcomes of patients undergoing total thyroidectomy deserves to be considered. Angiography-Guided Thyroidectomy has been proposed as a modification of the standard technique of thyroidectomy aimed to identifying the vascular pattern of the parathyroid glands to maximize efforts for preserving functioning glands at the time of operation. Our aim is to provide a technical description of this procedure based on the use of indocyanine green (ICG) angiography to standardize this technique.Methods: The surgical steps that are followed during a total thyroidectomy are modified due to previous visualization of the feeding vessels of the parathyroid glands according to fluorescence of the vascular mapping obtained by ICG angiography prior to thyroidectomy. The first step is to perform an ICG angiography to assess anatomical features of the feeding vasculature of the parathyroid glands, which allows precise surgical dissection for preservation of the glands. Once the viability of the parathyroids has been evaluated angiographically, thyroidectomy is performed in a second step.Conclusions: ICG angiography-guided thyroidectomy may be effective to preserve the largest number of better perfused parathyroid glands, which would contribute to reduce the risk of postoperative and permanent hypoparathyroidism. It can be successfully and safely implemented in thyroid surgery and standardization of the technique is necessary to homogenize this procedure in the future, allowing a better comparation of the results to be published.